Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Emergent BioSolutions Inc. Common Stock
(NY:
EBS
)
8.225
+0.095 (+1.17%)
Streaming Delayed Price
Updated: 11:20 AM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
165,173
Open
8.060
Bid (Size)
8.210 (300)
Ask (Size)
8.240 (100)
Prev. Close
8.130
Today's Range
7.995 - 8.280
52wk Range
5.615 - 14.06
Shares Outstanding
52,700,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
May 18, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent (EBS) Q1 2026 Earnings Transcript
↗
May 01, 2026
Emergent (EBS) Q1 2026 Earnings Transcript
Via
The Motley Fool
Performance
YTD
-34.3%
-34.3%
1 Month
-1.5%
-1.5%
3 Month
-23.1%
-23.1%
6 Month
-18.6%
-18.6%
1 Year
+22.2%
+22.2%
More News
Read More
Emergent BioSolutions (NYSE:EBS) Surges After Q1 Earnings Beat and Raised Profit Outlook
↗
April 30, 2026
Via
Chartmill
Topics
Earnings
Emergent BioSolutions Reports First Quarter 2026 Financial Results
April 30, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Inc (NYSE:EBS) Shares Tumble on Weak Q4 Results and Cautious 2026 Outlook
↗
February 26, 2026
Via
Chartmill
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
April 30, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
April 29, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
April 29, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
April 28, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent (EBS) Q4 2025 Earnings Transcript
↗
April 22, 2026
Via
The Motley Fool
Topics
Bonds
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
April 16, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
April 16, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
April 09, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
April 07, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
April 02, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
March 25, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
March 03, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
What's going on in today's pre-market session
↗
February 27, 2026
Via
Chartmill
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today?
↗
February 27, 2026
Via
Stocktwits
Topics
Earnings
Wondering what's happening in today's after-hours session?
↗
February 26, 2026
Via
Chartmill
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
February 26, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
February 12, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
From
Emergent BioSolutions
Via
GlobeNewswire
Frequently Asked Questions
Is Emergent BioSolutions Inc. Common Stock publicly traded?
Yes, Emergent BioSolutions Inc. Common Stock is publicly traded.
What exchange does Emergent BioSolutions Inc. Common Stock trade on?
Emergent BioSolutions Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Emergent BioSolutions Inc. Common Stock?
The ticker symbol for Emergent BioSolutions Inc. Common Stock is EBS on the New York Stock Exchange
What is the current price of Emergent BioSolutions Inc. Common Stock?
The current price of Emergent BioSolutions Inc. Common Stock is 8.225
When was Emergent BioSolutions Inc. Common Stock last traded?
The last trade of Emergent BioSolutions Inc. Common Stock was at 05/19/26 11:20 AM ET
What is the market capitalization of Emergent BioSolutions Inc. Common Stock?
The market capitalization of Emergent BioSolutions Inc. Common Stock is 433.46M
How many shares of Emergent BioSolutions Inc. Common Stock are outstanding?
Emergent BioSolutions Inc. Common Stock has 433M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today